Long-lasting efficacy of the cognitive enhancer cytotoxic necrotizing factor 1

Neuropharmacology. 2013 Jan:64:74-80. doi: 10.1016/j.neuropharm.2012.05.031. Epub 2012 May 31.

Abstract

Rho GTPases are key regulators of the activity-dependent changes of neural circuits. Besides being involved in nervous system development and repair, this neural structural plasticity is believed to constitute the cellular basis of learning and memory. Here we report that concurrent modulation of cerebral Rho GTPases, including Rac, Rho and Cdc42 subfamilies, by Cytotoxic Necrotizing Factor 1 (CNF1, 10 fmol/kg intracerebroventricularly) improves object recognition in both C57BL/6J and CD1 mice. The improvement is long lasting, as it is still observed 90 days post treatment. At this time, the treatment is associated with enhancement of neurotransmission and long-term potentiation. The effects depend on changes in Rho GTPase status, since the recombinant molecule CNF1 C866S, in which the enzymatic activity was abolished through substitution of serine to cysteine at position 866, is ineffective. The study confirms the role of Rho GTPases in learning and suggests that a single administration of CNF1 is effective for a long time after administration. In general, the long-lasting cognition enhancing effect of CNF1 might be beneficial for the treatment of CNS disorders. This article is part of a Special Issue entitled 'Cognitive Enhancers'.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Toxins / administration & dosage
  • Bacterial Toxins / genetics
  • Bacterial Toxins / metabolism
  • Bacterial Toxins / pharmacology*
  • CA1 Region, Hippocampal / drug effects*
  • CA1 Region, Hippocampal / enzymology
  • CA1 Region, Hippocampal / metabolism
  • Escherichia coli Proteins / administration & dosage
  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / metabolism
  • Escherichia coli Proteins / pharmacology*
  • Injections, Intraventricular
  • Learning / drug effects
  • Long-Term Potentiation / drug effects*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Nerve Tissue Proteins / antagonists & inhibitors*
  • Nerve Tissue Proteins / metabolism
  • Neurons / drug effects*
  • Neurons / enzymology
  • Neurons / metabolism
  • Nootropic Agents / administration & dosage
  • Nootropic Agents / metabolism
  • Nootropic Agents / pharmacology*
  • Performance-Enhancing Substances / administration & dosage
  • Performance-Enhancing Substances / metabolism
  • Performance-Enhancing Substances / pharmacology
  • Random Allocation
  • Recognition, Psychology / drug effects
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Species Specificity
  • Synaptic Transmission / drug effects
  • rho GTP-Binding Proteins / antagonists & inhibitors*
  • rho GTP-Binding Proteins / metabolism

Substances

  • Bacterial Toxins
  • Escherichia coli Proteins
  • Nerve Tissue Proteins
  • Nootropic Agents
  • Performance-Enhancing Substances
  • Recombinant Proteins
  • cytotoxic necrotizing factor type 1
  • rho GTP-Binding Proteins